Serveur d'exploration sur l'OCR

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice

Identifieur interne : 000352 ( PascalFrancis/Corpus ); précédent : 000351; suivant : 000353

Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice

Auteurs : K. K. Papas ; C. K. Colton ; R. A. Nelson ; P. R. Rozak ; E. S. Avgoustiniatos ; W. E. Iii Scott ; G. M. Wildey ; A. Pisania ; G. C. Weir ; B. J. Hering

Source :

RBID : Pascal:07-0165894

Descripteurs français

English descriptors

Abstract

There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  2    @0 1600-6135
A05       @2 7
A06       @2 3
A08 01  1  ENG  @1 Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice
A11 01  1    @1 PAPAS (K. K.)
A11 02  1    @1 COLTON (C. K.)
A11 03  1    @1 NELSON (R. A.)
A11 04  1    @1 ROZAK (P. R.)
A11 05  1    @1 AVGOUSTINIATOS (E. S.)
A11 06  1    @1 SCOTT (W. E. III)
A11 07  1    @1 WILDEY (G. M.)
A11 08  1    @1 PISANIA (A.)
A11 09  1    @1 WEIR (G. C.)
A11 10  1    @1 HERING (B. J.)
A14 01      @1 Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota @2 Minneapolis, MN @3 USA @Z 1 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 10 aut.
A14 02      @1 Department of Chemical Engineering, Massachusetts Institute of Technology @2 Cambridge, MA @3 USA @Z 2 aut. @Z 8 aut.
A14 03      @1 Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute @2 Duarte, CA @3 USA @Z 3 aut.
A14 04      @1 Joslin Diabetes Center, Harvard Medical School @2 Boston, MA @3 USA @Z 9 aut.
A20       @1 707-713
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 27587 @5 354000159369750280
A44       @0 0000 @1 © 2007 INIST-CNRS. All rights reserved.
A45       @0 24 ref.
A47 01  1    @0 07-0165894
A60       @1 P
A61       @0 A
A64 01  2    @0 American journal of transplantation
A66 01      @0 GBR
C01 01    ENG  @0 There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.
C02 01  X    @0 002B25
C02 02  X    @0 002B30A01A
C02 03  X    @0 002B21E01A
C03 01  X  FRE  @0 Mesure @5 01
C03 01  X  ENG  @0 Measurement @5 01
C03 01  X  SPA  @0 Medida @5 01
C03 02  X  FRE  @0 Homme @5 02
C03 02  X  ENG  @0 Human @5 02
C03 02  X  SPA  @0 Hombre @5 02
C03 03  X  FRE  @0 Ilot Langerhans @5 03
C03 03  X  ENG  @0 Langerhans islet @5 03
C03 03  X  SPA  @0 Isla Langerhans @5 03
C03 04  X  FRE  @0 Diabète @2 NM @5 04
C03 04  X  ENG  @0 Diabetes mellitus @2 NM @5 04
C03 04  X  SPA  @0 Diabetes @2 NM @5 04
C03 05  X  FRE  @0 Consommation oxygène @5 05
C03 05  X  ENG  @0 Oxygen consumption @5 05
C03 05  X  SPA  @0 Consumo oxígeno @5 05
C03 06  X  FRE  @0 Taux @5 06
C03 06  X  ENG  @0 Rate @5 06
C03 06  X  SPA  @0 Tasa @5 06
C03 07  X  FRE  @0 Epidémiologie @5 08
C03 07  X  ENG  @0 Epidemiology @5 08
C03 07  X  SPA  @0 Epidemiología @5 08
C03 08  X  FRE  @0 DNA @5 09
C03 08  X  ENG  @0 DNA @5 09
C03 08  X  SPA  @0 DNA @5 09
C03 09  X  FRE  @0 Facteur prédictif @5 11
C03 09  X  ENG  @0 Predictive factor @5 11
C03 09  X  SPA  @0 Factor predictivo @5 11
C03 10  X  FRE  @0 Prédiction @5 12
C03 10  X  ENG  @0 Prediction @5 12
C03 10  X  SPA  @0 Predicción @5 12
C03 11  X  FRE  @0 Réversibilité @5 17
C03 11  X  ENG  @0 Reversibility @5 17
C03 11  X  SPA  @0 Reversibilidad @5 17
C03 12  X  FRE  @0 Animal @5 18
C03 12  X  ENG  @0 Animal @5 18
C03 12  X  SPA  @0 Animal @5 18
C03 13  X  FRE  @0 Souris @5 19
C03 13  X  ENG  @0 Mouse @5 19
C03 13  X  SPA  @0 Ratón @5 19
C03 14  X  FRE  @0 Contrôle qualité @5 20
C03 14  X  ENG  @0 Quality control @5 20
C03 14  X  SPA  @0 Control calidad @5 20
C07 01  X  FRE  @0 Rodentia @2 NS
C07 01  X  ENG  @0 Rodentia @2 NS
C07 01  X  SPA  @0 Rodentia @2 NS
C07 02  X  FRE  @0 Mammalia @2 NS
C07 02  X  ENG  @0 Mammalia @2 NS
C07 02  X  SPA  @0 Mammalia @2 NS
C07 03  X  FRE  @0 Vertebrata @2 NS
C07 03  X  ENG  @0 Vertebrata @2 NS
C07 03  X  SPA  @0 Vertebrata @2 NS
C07 04  X  FRE  @0 Pancréas endocrine @5 37
C07 04  X  ENG  @0 Endocrine pancreas @5 37
C07 04  X  SPA  @0 Páncreas endocrino @5 37
C07 05  X  FRE  @0 Endocrinopathie @5 38
C07 05  X  ENG  @0 Endocrinopathy @5 38
C07 05  X  SPA  @0 Endocrinopatía @5 38
N21       @1 106
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 07-0165894 INIST
ET : Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice
AU : PAPAS (K. K.); COLTON (C. K.); NELSON (R. A.); ROZAK (P. R.); AVGOUSTINIATOS (E. S.); SCOTT (W. E. III); WILDEY (G. M.); PISANIA (A.); WEIR (G. C.); HERING (B. J.)
AF : Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota/Minneapolis, MN/Etats-Unis (1 aut., 4 aut., 5 aut., 6 aut., 7 aut., 10 aut.); Department of Chemical Engineering, Massachusetts Institute of Technology/Cambridge, MA/Etats-Unis (2 aut., 8 aut.); Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute/Duarte, CA/Etats-Unis (3 aut.); Joslin Diabetes Center, Harvard Medical School/Boston, MA/Etats-Unis (9 aut.)
DT : Publication en série; Niveau analytique
SO : American journal of transplantation; ISSN 1600-6135; Royaume-Uni; Da. 2007; Vol. 7; No. 3; Pp. 707-713; Bibl. 24 ref.
LA : Anglais
EA : There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.
CC : 002B25; 002B30A01A; 002B21E01A
FD : Mesure; Homme; Ilot Langerhans; Diabète; Consommation oxygène; Taux; Epidémiologie; DNA; Facteur prédictif; Prédiction; Réversibilité; Animal; Souris; Contrôle qualité
FG : Rodentia; Mammalia; Vertebrata; Pancréas endocrine; Endocrinopathie
ED : Measurement; Human; Langerhans islet; Diabetes mellitus; Oxygen consumption; Rate; Epidemiology; DNA; Predictive factor; Prediction; Reversibility; Animal; Mouse; Quality control
EG : Rodentia; Mammalia; Vertebrata; Endocrine pancreas; Endocrinopathy
SD : Medida; Hombre; Isla Langerhans; Diabetes; Consumo oxígeno; Tasa; Epidemiología; DNA; Factor predictivo; Predicción; Reversibilidad; Animal; Ratón; Control calidad
LO : INIST-27587.354000159369750280
ID : 07-0165894

Links to Exploration step

Pascal:07-0165894

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice</title>
<author>
<name sortKey="Papas, K K" sort="Papas, K K" uniqKey="Papas K" first="K. K." last="Papas">K. K. Papas</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Colton, C K" sort="Colton, C K" uniqKey="Colton C" first="C. K." last="Colton">C. K. Colton</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Chemical Engineering, Massachusetts Institute of Technology</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Nelson, R A" sort="Nelson, R A" uniqKey="Nelson R" first="R. A." last="Nelson">R. A. Nelson</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute</s1>
<s2>Duarte, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rozak, P R" sort="Rozak, P R" uniqKey="Rozak P" first="P. R." last="Rozak">P. R. Rozak</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Avgoustiniatos, E S" sort="Avgoustiniatos, E S" uniqKey="Avgoustiniatos E" first="E. S." last="Avgoustiniatos">E. S. Avgoustiniatos</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Scott, W E Iii" sort="Scott, W E Iii" uniqKey="Scott W" first="W. E. Iii" last="Scott">W. E. Iii Scott</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wildey, G M" sort="Wildey, G M" uniqKey="Wildey G" first="G. M." last="Wildey">G. M. Wildey</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pisania, A" sort="Pisania, A" uniqKey="Pisania A" first="A." last="Pisania">A. Pisania</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Chemical Engineering, Massachusetts Institute of Technology</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Weir, G C" sort="Weir, G C" uniqKey="Weir G" first="G. C." last="Weir">G. C. Weir</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Joslin Diabetes Center, Harvard Medical School</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hering, B J" sort="Hering, B J" uniqKey="Hering B" first="B. J." last="Hering">B. J. Hering</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0165894</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0165894 INIST</idno>
<idno type="RBID">Pascal:07-0165894</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000352</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice</title>
<author>
<name sortKey="Papas, K K" sort="Papas, K K" uniqKey="Papas K" first="K. K." last="Papas">K. K. Papas</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Colton, C K" sort="Colton, C K" uniqKey="Colton C" first="C. K." last="Colton">C. K. Colton</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Chemical Engineering, Massachusetts Institute of Technology</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Nelson, R A" sort="Nelson, R A" uniqKey="Nelson R" first="R. A." last="Nelson">R. A. Nelson</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute</s1>
<s2>Duarte, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rozak, P R" sort="Rozak, P R" uniqKey="Rozak P" first="P. R." last="Rozak">P. R. Rozak</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Avgoustiniatos, E S" sort="Avgoustiniatos, E S" uniqKey="Avgoustiniatos E" first="E. S." last="Avgoustiniatos">E. S. Avgoustiniatos</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Scott, W E Iii" sort="Scott, W E Iii" uniqKey="Scott W" first="W. E. Iii" last="Scott">W. E. Iii Scott</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wildey, G M" sort="Wildey, G M" uniqKey="Wildey G" first="G. M." last="Wildey">G. M. Wildey</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pisania, A" sort="Pisania, A" uniqKey="Pisania A" first="A." last="Pisania">A. Pisania</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Chemical Engineering, Massachusetts Institute of Technology</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Weir, G C" sort="Weir, G C" uniqKey="Weir G" first="G. C." last="Weir">G. C. Weir</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Joslin Diabetes Center, Harvard Medical School</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hering, B J" sort="Hering, B J" uniqKey="Hering B" first="B. J." last="Hering">B. J. Hering</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">American journal of transplantation</title>
<idno type="ISSN">1600-6135</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">American journal of transplantation</title>
<idno type="ISSN">1600-6135</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>DNA</term>
<term>Diabetes mellitus</term>
<term>Epidemiology</term>
<term>Human</term>
<term>Langerhans islet</term>
<term>Measurement</term>
<term>Mouse</term>
<term>Oxygen consumption</term>
<term>Prediction</term>
<term>Predictive factor</term>
<term>Quality control</term>
<term>Rate</term>
<term>Reversibility</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Mesure</term>
<term>Homme</term>
<term>Ilot Langerhans</term>
<term>Diabète</term>
<term>Consommation oxygène</term>
<term>Taux</term>
<term>Epidémiologie</term>
<term>DNA</term>
<term>Facteur prédictif</term>
<term>Prédiction</term>
<term>Réversibilité</term>
<term>Animal</term>
<term>Souris</term>
<term>Contrôle qualité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="2">
<s0>1600-6135</s0>
</fA01>
<fA05>
<s2>7</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PAPAS (K. K.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>COLTON (C. K.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>NELSON (R. A.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>ROZAK (P. R.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>AVGOUSTINIATOS (E. S.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>SCOTT (W. E. III)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>WILDEY (G. M.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>PISANIA (A.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>WEIR (G. C.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>HERING (B. J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Chemical Engineering, Massachusetts Institute of Technology</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute</s1>
<s2>Duarte, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Joslin Diabetes Center, Harvard Medical School</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA20>
<s1>707-713</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>27587</s2>
<s5>354000159369750280</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>24 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>07-0165894</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="2">
<s0>American journal of transplantation</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B25</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B30A01A</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B21E01A</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Mesure</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Measurement</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Medida</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Ilot Langerhans</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Langerhans islet</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Isla Langerhans</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Diabète</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Diabetes mellitus</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Diabetes</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Consommation oxygène</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Oxygen consumption</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Consumo oxígeno</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Taux</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Rate</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Tasa</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>DNA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>DNA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>DNA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Facteur prédictif</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Predictive factor</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Factor predictivo</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Prédiction</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Prediction</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Predicción</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Réversibilité</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Reversibility</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Reversibilidad</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Animal</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Animal</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Animal</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Souris</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Contrôle qualité</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Quality control</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Control calidad</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pancréas endocrine</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Endocrine pancreas</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Páncreas endocrino</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Endocrinopathie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Endocrinopathy</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Endocrinopatía</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>106</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 07-0165894 INIST</NO>
<ET>Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice</ET>
<AU>PAPAS (K. K.); COLTON (C. K.); NELSON (R. A.); ROZAK (P. R.); AVGOUSTINIATOS (E. S.); SCOTT (W. E. III); WILDEY (G. M.); PISANIA (A.); WEIR (G. C.); HERING (B. J.)</AU>
<AF>Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota/Minneapolis, MN/Etats-Unis (1 aut., 4 aut., 5 aut., 6 aut., 7 aut., 10 aut.); Department of Chemical Engineering, Massachusetts Institute of Technology/Cambridge, MA/Etats-Unis (2 aut., 8 aut.); Administrative and Bioinformatics Coordinating Center (ABCC) for the Islet Cell Resource (ICR) Center Consortium, City of Hope National Medical Center and Beckman Research Institute/Duarte, CA/Etats-Unis (3 aut.); Joslin Diabetes Center, Harvard Medical School/Boston, MA/Etats-Unis (9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>American journal of transplantation; ISSN 1600-6135; Royaume-Uni; Da. 2007; Vol. 7; No. 3; Pp. 707-713; Bibl. 24 ref.</SO>
<LA>Anglais</LA>
<EA>There is a need for simple, quantitative and prospective assays for islet quality assessment that are predictive of islet transplantation outcome. The current state-of-the-art athymic nude mouse bioassay is costly, technically challenging and retrospective. In this study, we report on the ability of 2 parameters characterizing human islet quality: (1) oxygen consumption rate (OCR), a measure of viable volume; and (2) OCR/DNA, a measure of fractional viability, to predict diabetes reversal in nude mice. Results demonstrate that the probability for diabetes reversal increases as the graft's OCR/DNA and total OCR increase. For a given transplanted OCR dose, diabetes reversal is strongly dependent on OCR/DNA. The OCR and OCR/DNA (the 'OCR test') data exhibit 89% sensitivity and 77% specificity in predicting diabetes reversal in nude mice (n = 86). We conclude that the prospective OCR test can effectively replace the retrospective athymic nude mouse bioassay in assessing human islet quality prior to islet transplantation.</EA>
<CC>002B25; 002B30A01A; 002B21E01A</CC>
<FD>Mesure; Homme; Ilot Langerhans; Diabète; Consommation oxygène; Taux; Epidémiologie; DNA; Facteur prédictif; Prédiction; Réversibilité; Animal; Souris; Contrôle qualité</FD>
<FG>Rodentia; Mammalia; Vertebrata; Pancréas endocrine; Endocrinopathie</FG>
<ED>Measurement; Human; Langerhans islet; Diabetes mellitus; Oxygen consumption; Rate; Epidemiology; DNA; Predictive factor; Prediction; Reversibility; Animal; Mouse; Quality control</ED>
<EG>Rodentia; Mammalia; Vertebrata; Endocrine pancreas; Endocrinopathy</EG>
<SD>Medida; Hombre; Isla Langerhans; Diabetes; Consumo oxígeno; Tasa; Epidemiología; DNA; Factor predictivo; Predicción; Reversibilidad; Animal; Ratón; Control calidad</SD>
<LO>INIST-27587.354000159369750280</LO>
<ID>07-0165894</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/OcrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000352 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000352 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    OcrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0165894
   |texte=   Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Sat Nov 11 16:53:45 2017. Site generation: Mon Mar 11 23:15:16 2024